Pfizer ' s Trastuzumab Biosimilar Noninferior in Two Breast Ca Trials
(MedPage Today) -- Results similar to branded drug in metastatic, neoadjuvant breast cancer studies
Source: MedPage Today OB/GYN - Category: OBGYN Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Herceptin | Neoadjuvant Therapy | OBGYN | Pfizer | Study